NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Cost of Revenue in USD from Q1 2018 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Navidea Biopharmaceuticals, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2018 to Q4 2022.
  • Navidea Biopharmaceuticals, Inc. Cost of Revenue for the quarter ending December 31, 2022 was $36.000.
  • Navidea Biopharmaceuticals, Inc. Cost of Revenue for the twelve months ending December 31, 2022 was $1.94K.
  • Navidea Biopharmaceuticals, Inc. annual Cost of Revenue for 2022 was $1.94K.
  • Navidea Biopharmaceuticals, Inc. annual Cost of Revenue for 2021 was $0.000, a 100% decline from 2020.
  • Navidea Biopharmaceuticals, Inc. annual Cost of Revenue for 2020 was $1.05K, a 84.3% decline from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $1.94K $36.00 +$36.00 Oct 1, 2022 Dec 31, 2022 10-K 2023-03-27
Q3 2022 $1.91K $1.43K +$1.43K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $473 $473 +$473 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $0 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $0 $0 $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 $0 $0 -$82 -100% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $82.00 $0 -$357 -100% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $439 $0 -$609 -100% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $1.05K $0 -$108 -100% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $1.16K $82.00 -$113 -57.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $1.27K $357 +$119 +50% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $1.15K $609 -$5.52K -90.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $6.67K $108 -$22.7K -99.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-26
Q3 2019 $29.4K $195 -$37.9K -99.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $67.3K $238 -$35.2K -99.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $102K $6.13K +$5.81K +1826% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $96.6K $22.8K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-18
Q3 2018 $38.1K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $35.4K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $318 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.